Peptide Stack
Sermorelin + ipamorelin stack
A GH-support stack intended to combine GHRH signaling with ghrelin-receptor stimulation for recovery and sleep support.
In depth
Why these two are paired
This stack follows the same dual-receptor logic as CJC-1295 plus ipamorelin — a GHRH analog paired with a ghrelin-receptor agonist — but built around sermorelin, the shorter-acting, FDA-precedented GHRH analog, instead of CJC-1295.
What's actually established
Sermorelin carries the most regulatory and clinical history of any GHRH analog in this index, including a former FDA approval; ipamorelin's foundational selectivity data comes from a separate 1998 study. As with the CJC-1295 version of this stack, the combination itself has not been directly tested in a controlled trial.
Safety
The combined side-effect profile is additive — flushing, headache, and injection-site reactions from each component. Sermorelin's shorter half-life relative to CJC-1295 typically means more frequent dosing in protocols built around it.
Detail
Overview
A GH-support stack intended to combine GHRH signaling with ghrelin-receptor stimulation for recovery and sleep support.
Benefits, side effects, and protocols
Benefits list
Side effects
Vendor protocol
- None listed
Clinical protocol
- None listed
Evidence
- Low
Regulatory
- Not Fda Approved
Research
Mechanisms
Evidence notes
- Low
Administration
Research links
Contraindications
- None listed
Components
Regulatory data
- Not Fda Approved
Aliases
- None listed
Related compounds
Frequently asked questions
What is the sermorelin and ipamorelin stack?
A GH-axis stack pairing sermorelin, a GHRH-receptor agonist, with ipamorelin, a ghrelin-receptor agonist, aiming to stimulate GH release through two different pituitary pathways.
Sermorelin plus ipamorelin vs. CJC-1295 plus ipamorelin — what's the difference?
The difference is in the GHRH-analog half: sermorelin is shorter-acting with FDA precedent, while CJC-1295 is longer-acting and was never FDA approved.
Is this stack FDA approved?
No. Sermorelin was formerly FDA approved as a standalone product (discontinued in 2008 for commercial reasons), but ipamorelin is not, and the combination has not been evaluated by any regulator.
Educational reference only. Pepperz does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing recommendations. Sourcing Sermorelin + ipamorelin stack? Check your source before you use anything.